Literature DB >> 11447743

Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue.

P L Alò1, P Visca, C Botti, G M Galati, V Sebastiani, T Andreano, U Di Tondo, E S Pizer.   

Abstract

To evaluate the immunohistochemical expression of GLUT1, human erythrocyte glucose transporter 1, and fatty acid synthase (FAS), 66 human breast carcinomas and adjacent peritumoral tissue were studied. GLUT1 and FAS were expressed in 53 and 61 carcinomas, in 17 and 14 typical/atypical hyperplastic tissues, and in 16 and 13 tissues adjacent to tumor normal breast tissue, respectively. Statistical analysis revealed association between invasive carcinomas, invasive carcinomas with in situ component and GLUT1 immunostaining. GLUT1 staining was associated with tumor grade, FAS with tumor stage, and GLUT1 and FAS coexpression with tumor grade. Controls expressed no immunostaining. GLUT1 and FAS are new markers involved in the biologic activities of cancer cells. GLUT1 and FAS coexpression may indicate increased use of energy by the neoplastic cells correlated with poorly differentiated features and aggressive behavior. The innovative finding that GLUT1 and FAS are observed in mammary carcinoma adjacent nonneoplastic tissues may suggest a role in detecting initial phases of breast carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447743     DOI: 10.1309/5Y2L-CDCK-YB55-KDK6

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  17 in total

1.  Comparative metabolic analysis in head and neck cancer and the normal gingiva.

Authors:  Nadine Fabienne Voelxen; Sebastian Blatt; Pascal Knopf; Maurice Henkel; Christina Appelhans; Leonardo A R Righesso; Andreas Pabst; Jutta Goldschmitt; Stefan Walenta; Andreas Neff; Wolfgang Mueller-Klieser; Thomas Ziebart
Journal:  Clin Oral Investig       Date:  2017-07-22       Impact factor: 3.573

2.  The expression of glutamine-metabolism-related proteins in breast phyllodes tumors.

Authors:  Sewha Kim; Woo Hee Jung; Ja Seung Koo
Journal:  Tumour Biol       Date:  2013-05-01

3.  Progressive increase of glucose transporter-3 (GLUT-3) expression in estrogen-induced breast carcinogenesis.

Authors:  M A Kocdor; H Kocdor; J S Pereira; J E Vanegas; I H Russo; J Russo
Journal:  Clin Transl Oncol       Date:  2012-10-02       Impact factor: 3.405

4.  GLUT1 participates in tamoxifen resistance in breast cancer cells through autophagy regulation.

Authors:  Mengqi Sun; Shu Zhao; Yuchen Duan; Yumeng Ma; Yicheng Wang; Hongfei Ji; Qingyuan Zhang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-06-05       Impact factor: 3.000

5.  Occurrence of differing metabolic dysregulations, a glucose driven and another fatty acid centric in gastric cancer subtypes.

Authors:  Karthik Balakrishnan; Kumaresan Ganesan
Journal:  Funct Integr Genomics       Date:  2020-09-19       Impact factor: 3.410

6.  Glut-1 Expression Correlates with Basal-like Breast Cancer.

Authors:  Yaser R Hussein; Sudeshna Bandyopadhyay; Assaad Semaan; Quratulain Ahmed; Bassam Albashiti; Tarek Jazaerly; Zeina Nahleh; Rouba Ali-Fehmi
Journal:  Transl Oncol       Date:  2011-12-01       Impact factor: 4.243

7.  Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells.

Authors:  Yong Yang; Joy Wolfram; Kathryn Boom; Xiaohong Fang; Haifa Shen; Mauro Ferrari
Journal:  Cell Biochem Funct       Date:  2012-10-08       Impact factor: 3.685

8.  Expression of metabolism-related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.

Authors:  Yon Hee Kim; Woo Hee Jung; Ja Seung Koo
Journal:  Tumour Biol       Date:  2014-07-23

9.  The expression of metabolism-related proteins in phyllodes tumors.

Authors:  Ji Eun Kwon; Woo-Hee Jung; Ja Seung Koo
Journal:  Tumour Biol       Date:  2012-09-18

10.  Fatty acid synthase inhibition results in a magnetic resonance-detectable drop in phosphocholine.

Authors:  James Ross; Amer M Najjar; Madhuri Sankaranarayanapillai; William P Tong; Kumaralal Kaluarachchi; Sabrina M Ronen
Journal:  Mol Cancer Ther       Date:  2008-08       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.